NIH-Backed Startup Amissa Unveils AI Platform to Improve Menopause Care
NIH-backed startup Amissa has launched an AI-powered platform that aggregates data from multiple sources to improve how menopause and perimenopause are tracked and treated.
Microplastics Are in Our Blood — Why Aren’t Federal Regulators Acting?
The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale.
presented by
MedCity News Pivot Podcast: How Emergency Departments Are Using Real-Time Data to Improve Outcomes
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Federal Cuts Only Worsen Health’s Ransomware Problem
Let’s not add salt to the wound of funding cuts and personnel changes by inadvertently inviting even more ransomware - here's a closer look at health’s endpoint holes, how federal cuts could ultimately help ransomware hackers, and what ecosystem defenders can do to step up and fight back.
Debunked Episode 17: Is Big Pharma Prepared for Impact of Trump Administration’s Health Policies?
The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.
‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the Health of Americans’
The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than 1,000 employees this year; and moving to end billions in funds to partner institutions overseas.
NIH Cuts: A Push for Efficiency or a Blow to US Healthcare Innovation?
The Trump administration recently cancelled billions of dollars in funding to the NIH. Healthcare experts say the funding cuts will delay the pace of medical research in the U.S. — which will not only hamper the commercialization of life-saving treatments, but could also hurt the country’s position as a global leader in healthcare and technology.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
How One Company is Using an Armband to Combat the Overdose Crisis
Ayuda Medical offers a wearable device that can detect an overdose and call for help. The company has received support from the NIH and NIDA via the Small Business Innovation Research program.
An Update on Gun Violence as a Public Health Issue
Gun violence is a public health crisis, and lawmakers are taking small steps toward treating it that way, said Kris Brown, president of gun violence prevention nonprofit Brady United. But there is still a long road ahead in the fight to protect American communities against gun-related injuries and fatalities, she said.
Government Money: The most effective weapon in the fight against Covid-19
Many people complain about the government – probably with good reason – but the policies surrounding non-dilutive life science R&D are policies that deserve praise, and are the ones that all politicians and leaders, no matter their party affiliation, will support.
Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns
The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19
The NIAID create the Covid-19 Prevention Trials Network by combining four existing ones, primarily focused on HIV and AIDS, which will continue that work in addition to their new focus on Covid-19.
Report: Japanese PM suggests approval of Gilead’s Covid-19 drug despite ‘equivocal’ data
It was also reported that a study sponsored by the National Institutes of Health was running ahead of schedule and could have data available in the next couple of weeks.
NIH opens Phase II coronavirus trial with Gilead drug at University of Nebraska
The randomized, placebo-controlled study of Gilead's remdesivir has been posted online and has enrolled the first patient, one of the passengers on a quarantined cruise ship docked off of Yokohama, Japan, who was repatriated to the U.S.
Scripps study: Can your Fitbit track the flu?
A new study by the Scripps Research Translational Institute suggests Fitbits could be used to detect the flu. By tracking resting heart rate and activity levels, researchers said Fitbits could improve detection of outbreaks at the state level.
All of Us caps one-year anniversary with the release of new data browser tool
More than 230,000 people have started the process of joining the research program and more than 142,000 have completed the program's first research protocol.